06051228 is referenced by 81 patents and cites 4 patents.

The Applicants have discovered a novel antibody, more specifically a chimerized anti-human CD40 monoclonal antibody, which blocks the interaction between gp39 and CD40. The anti-CD40 antibodies of the present invention are effective in modulating humoral immune responses against T cell-dependent antigens, collagen induced arthritis, and skin transplantation, and are also useful for their anti-inflammatory properties.

Title
Antibodies against human CD40
Application Number
9/26291
Publication Number
6051228
Application Date
February 19, 1998
Publication Date
April 18, 2000
Inventor
Jurgen Bajorath
Lynnwood
WA, US
Barbara A Thorne
Issaquah
WA, US
Linda Harris
Seattle
WA, US
Karen K Berry
Princeton
NJ, US
Anthony W Siadak
Seattle
WA, US
Diane Hollenbaugh
Newtown
PA, US
Alejandro A Aruffo
Belle Mead
NJ, US
Agent
Audrey F Sher
Christopher A Klein
Assignee
Bristol Myers Squibb Co
NY, US
IPC
C12N 1/21
C12N 15/13
C07K 16/28
A61K 39/395
View Original Source